Preliminary optimisation of a simplified sample preparation method to permit direct detection of SARS-CoV-2 within saliva samples using reverse-transcription loop-mediated isothermal amplification (RT-LAMP).
COVID-19
Direct detection
Near patient testing
RT-LAMP
Rapid diagnostics
SARS-CoV-2
Saliva
Journal
Journal of virological methods
ISSN: 1879-0984
Titre abrégé: J Virol Methods
Pays: Netherlands
ID NLM: 8005839
Informations de publication
Date de publication:
03 2021
03 2021
Historique:
received:
13
08
2020
revised:
28
11
2020
accepted:
12
12
2020
pubmed:
29
12
2020
medline:
9
2
2021
entrez:
28
12
2020
Statut:
ppublish
Résumé
We describe the optimisation of a simplified sample preparation method which permits rapid and direct detection of SARS-CoV-2 RNA within saliva, using reverse-transcription loop-mediated isothermal amplification (RT-LAMP). Treatment of saliva samples prior to RT-LAMP by dilution 1:1 in Mucolyse™, followed by dilution in 10 % (w/v) Chelex© 100 Resin and a 98 °C heat step for 2 min enabled detection of SARS-CoV-2 RNA in positive saliva samples. Using RT-LAMP, SARS-CoV-2 RNA was detected in as little as 05:43 min, with no amplification detected in 3097 real-time reverse transcription PCR (rRT-PCR) negative saliva samples from staff tested within a service evaluation study, or for other respiratory pathogens tested (n = 22). Saliva samples can be collected non-invasively, without the need for skilled staff and can be obtained from both healthcare and home settings. Critically, this approach overcomes the requirement for, and validation of, different swabs and the global bottleneck in obtaining access to extraction robots and reagents to enable molecular testing by rRT-PCR. Such testing opens the possibility of public health approaches for effective intervention during the COVID-19 pandemic through regular SARS-CoV-2 testing at a population scale, combined with isolation and contact tracing.
Identifiants
pubmed: 33358911
pii: S0166-0934(20)30300-1
doi: 10.1016/j.jviromet.2020.114048
pmc: PMC7750029
pii:
doi:
Substances chimiques
RNA, Viral
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
114048Subventions
Organisme : Medical Research Council
ID : MC_PC_21001
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_21003
Pays : United Kingdom
Informations de copyright
Copyright © 2020 Elsevier B.V. All rights reserved.
Références
Nucleic Acids Res. 2000 Jun 15;28(12):E63
pubmed: 10871386
J Virol Methods. 2016 Aug;234:123-31
pubmed: 27118518
Lancet. 2020 May 2;395(10234):1420-1421
pubmed: 32325027
Front Cell Infect Microbiol. 2020 Mar 24;10:115
pubmed: 32266166
Nature. 2020 Oct;586(7830):589-593
pubmed: 32785213
Sci Rep. 2021 Mar 9;11(1):5448
pubmed: 33750853
N Engl J Med. 2020 Dec 17;383(25):2427-2438
pubmed: 32991794
Clin Microbiol Infect. 2020 Jun;26(6):773-779
pubmed: 32276116
J Virol. 2011 Apr;85(8):4025-30
pubmed: 21289121
J Infect. 2020 Sep;81(3):e48-e50
pubmed: 32593658
Cureus. 2020 Apr 17;12(4):e7708
pubmed: 32313785
Lancet. 2020 Aug 15;396(10249):467-478
pubmed: 32702298
Euro Surveill. 2020 Jan;25(3):
pubmed: 31992387
J Infect. 2020 Sep;81(3):e75-e78
pubmed: 32579988
Transbound Emerg Dis. 2019 Jan;66(1):497-504
pubmed: 30372584
J Infect. 2021 Jan;82(1):117-125
pubmed: 33271166
Oral Dis. 2021 Apr;27 Suppl 3:707-709
pubmed: 32333518
FEMS Immunol Med Microbiol. 2011 Jun;62(1):41-8
pubmed: 21276085
J Infect. 2020 Jul;81(1):e45-e50
pubmed: 32298676